Tech Center 1600 • Art Units: 1637 1656 1681
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18314437 | SPATIALLY DISTINGUISHED, MULTIPLEX NUCLEIC ACID ANALYSIS OF BIOLOGICAL SPECIMENS | Final Rejection | Illumina, Inc. |
| 17254886 | CRISPR DOUBLE NICKASE BASED AMPLIFICATION COMPOSITIONS, SYSTEMS, AND METHODS | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 18016776 | COMPOSITIONS AND METHODS OF ISOTHERMAL NUCLEIC ACID AMPLIFICATION AND DETECTION | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 19251040 | SYNTHESIS OF DNA MOLECULES IN IN VITRO ENZYMATIC SYSTEMS | Final Rejection | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES |
| 18813886 | COMPOSITIONS AND METHODS FOR DETECTING BINDING INTERACTIONS UNDER EQUILIBRIUM OR NON-EQUILIBRIUM CONDITIONS | Final Rejection | Nautilus Subsidiary, Inc. |
| 18251596 | METHODS FOR FULL-LENGTH REVERSE TRANSCRIPTION PCR OF LONG RNAs CONTAINING MODIFIED RIBONUCLEOSIDES USING A THERMOSTABLE REVERSE TRANSCRIPTASE | Non-Final OA | Northwestern University |
| 17821424 | SCREENING OF NUCLEIC ACID SEQUENCE VARIATIONS VIA RANDOM LOADING OF OPTICALLY-ENCODED PARTICLES | Final Rejection | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 16611799 | QUANTITATIVE DETECTION AND ANALYSIS OF TARGET DNA WITH COLORIMETRIC RT-QLAMP | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18433015 | COMPOSITIONS AND METHODS FOR MULTIPLEXED QUANTITATIVE ANALYSIS OF CELL LINEAGES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18324552 | SINGLE-STRANDED NUCLEIC ACID APTAMERS SPECIFICALLY BINDING TO CRONOBACTER AND KIT FOR DETECTING CRONOBACTER USING THE SAME | Final Rejection | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18122657 | MODIFIED NUCLEOSIDE PHOSPHATES WITH HIGH THERMAL STABILITY | Non-Final OA | Roche Molecular Systems, Inc. |
| 18317484 | COMPOSITIONS AND METHODS FOR IMMUNE REPERTOIRE MONITORING | Non-Final OA | Life Technologies Corporation |
| 18137956 | Methods and Kits to Detect Viral Particle Heterogeneity | Final Rejection | LIFE TECHNOLOGIES CORPORATION |
| 16497143 | POLYNUCLEOTIDE ADAPTERS AND METHODS OF USE THEREOF | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 17933753 | METHODS AND COMPOSITIONS FOR PROCESSING BOTANICAL MATERIALS | Non-Final OA | The Chinese University of Hong Kong |
| 17928702 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | Non-Final OA | KEMIRA OYJ |
| 17999023 | METHODS FOR PAIRED-END SEQUENCING LIBRARY PREPARATION | Non-Final OA | Element Biosciences, Inc. |
| 16757297 | METHODS AND COMPOSITIONS FOR THE PURIFICATION OF UNBIASED RNA | Final Rejection | ZYMO RESEARCH CORPORATION |
| 18395034 | VIABLE CELL DETECTION AND PROTOCOL IMPLEMENTING THE SAME | Non-Final OA | Trace-Ability, Inc. |
| 18132703 | METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING | Non-Final OA | ULTIMA GENOMICS, INC. |
| 17311263 | CONTROLLING DNA CONCENTRATION FOR STR ANALYSIS | Final Rejection | Integenx, Inc. |
| 18349394 | COMPOSITION AND THE USE OF CELL LYSIS REAGENTS | Non-Final OA | Vilnius University |
| 17639399 | SKIN MICROBIOME MONITORING FOR IMPROVING SYSTEMIC HEALTH | Final Rejection | MY-OR DIAGNOSTICS LTD. |
| 18204703 | DETECTION OF TARGET NUCLEIC ACIDS | Non-Final OA | Saga Diagnostics AB |
| 18060421 | MODIFIED PRIMERS FOR LOOP-MEDIATED ISOTHERMAL AMPLIFICATION AND USE THEREOF | Final Rejection | 1DROP INC. |
| 17964798 | NUCLEIC ACID CONSTRUCTS AND METHODS OF USE | Non-Final OA | Prognosys Biosciences, Inc. |
| 17774249 | BIVALENT REVERSE PRIMER | Non-Final OA | MIRNAX BIOSENS, S.L. |
| 17632705 | METHODS FOR THE MULTIPLEXED ISOTHERMAL AMPLIFICATION OF NUCLEIC ACID SEQUENCES | Final Rejection | DNAE DIAGNOSTICS LIMITED |
| 17614892 | Detection of Antibiotic Resistance Genes | Non-Final OA | STRECK, INC. |
| 17293085 | MULTIMER FOR SEQUENCING AND METHODS FOR PREPARING AND ANALYZING THE SAME | Non-Final OA | FORESEE GENOMICS, LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy